Health Condition 1: E282- Polycystic ovarian syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -All married & unmarried cases -USG with polycystic ovaries showing multiple small peripheral follicles( >12 follicles)in each ovary measuring 2-9mm in diameter and/or increased ovarian volume >10mm. -All cases of PCOS having amenorrhoea/oligomenorrhoea. -PCOS patients having signs of hyperandrogenism
Exclusion criteria
Exclusion criteria: -Amenorrhoea of menopause -Patients of PCOS with DM/HTN/Hypothyroidism/Hyperthyroidism/TB/HIV/HbSAg/VDRL -Cases of prgnancy,cervical tumor/polyp, uterine fibroid -known cases of systemic illness like asthma,cardiovascular and renal diseases,malignancy, Salpingo oophoritis, Cervical erosion, anatomical defective genitalia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| -To observe the histopathological changes & steroidogenic enzyme activity in ovary in the Laterozole induced PCOS rat animal after administration of Shatapushpa churna -To evaluate the ovulatory effects of Shatapushpa churna in Latrazole induced PCOS in rat animal -To study the clinical action of Shatapushpa Churna in PCOS by assessing ovulatory effects ,reduction in ovarion volume and status of menstruation.Timepoint: 9 MONTHS | — |
Secondary
| Measure | Time frame |
|---|---|
| -To evaluate the effects of Shatapushpa churna in PCOS by assessing the changes in biochemical markers like FSH LH E2 TESTOSTERON DHEAS GTT SERUM LIPID PROFILE SERUM INSULIN LEVEL -To assess the effect of Shatapushpa churna in Achanthosis Nigrans Hirsutism AcneTimepoint: 9 MONTHS | — |
Countries
India
Contacts
R A Podar Ayurved Medical College